New Delhi: Surgical robot of a globally renowned Indian doctor is in the advanced stage of making and is billed to give da Vinci a run for its money. The upshot of it would make robotic surgeries dirt cheap compared to what its costs today. Its clinical trial is all set to start in India next year. If disruption is the credo of present time, the advent of this new surgical robot called Mantra will be the most momentous of sort in healthcare. SS Innovations, a company founded by Dr Sudhir Srivastava, is making the new surgical robot that is generating much
anticipation throughout the world. Dr Srivastava is a global expert in robot assisted cardiac surgery, making an indelible mark in USA. Talking to this writer, Dr Srivastava said, ‘My Mantra robot will cost only Rs 4 crore while da Vinci’s cost is astronomical Rs 18 crore. Surgical robot is undoubtedly the best tool for surgery but cost of this surgery is a deterrent in the way of it becoming the norm. When Mantra comes, which is imminent, will change all that. I wanted that more and more people should be able to afford robotic surgery which is the gold standard. This vision was what prompted me to go for such ambitious project ’ ‘By the end of this year, assembly of robots will start and clinical trials will begin in India next year. It will be better than all other surgical robots which might enter the market in times to come and da Vinci which has monopoly at present. Mantra would be a surgical robot for all specialities including heart. Our focus is that robot should be successful in heart surgery,’added Dr Srivastava.
Dr Srivastava has got funding from China. According to him 70 people in SS Innovations are working for giving finishing touch to Mantra. In Andhra Med Tech Zone (AMTZ) in AP, SS Innovations has taken 40 thousand sq foot area on lease for 35 years. The area where Mantra will be assembled is in the works. SS Innovations has offices in China and USA as well. For now, da Vinci of Intuitive Inc is the only surgical robot. CMR Surgical and Medtronic are two other companies which are bound to challenge da Vinci’s monopoly. Mantra will not only be cheap it will be easy for use as well. Dr Srivastava says that Mantra will be surgical robot though for developing world but as efficient as da Vinci is or even better. The global surgical robotics market is on the cusp of boom and is all set to reach $12.6 billion by 2025. The da Vinci Surgical System alone has been used to treat more than three million patients. For some procedures, like prostate surgery, it is now the gold standard. But surgery from da Vinci is not affordable for commoners. Dr Srivastava founded SS Innovations in China in 2017. According to Srivastava, now available surgical robotic systems are far too expensive and take years to master. As a result very few surgeons are trained to operate these systems and much of the world is unable to access this technology.SSI recently tested its system on 10 animals for one exploratory laparotomy with promising results.
- September 23, 2019
Dr Saumitra Rawat
M.S, FRCS(Eng), FRCS(Glas), FRCS(Edin), FRCS(Intercollegiate), CCST(UK)
Awarded Padmashri by Hon’ble President of India
Chairman and Head
Department of Surgical Gastroenterology and Liver Transplant
Sir Ganga Ram Hospital, New Delhi
Member, Court of Examiner, Royal College of Surgeons of England
Laparoscopic Trainer, Royal College of Surgeons of England
Programme Director, International Fellowship in Laparoscopic Surgery /Surgical Oncology,
Sir Ganga Ram Hospital and Christie's Hospital, UK
Formerly Consultant Surgeon, East Cheshire NHS Trust, UK
Formerly Consultant Surgeon, Glasgow Royal Infirmary, UK
Formerly Honorary Consultant Surgeon, Christie Hospital, Manchester, UK
Formerly Surgical tutor, Royal College of Surgeon of England
Cancer is now one of the top causes of death in India, second after heart attack, up from
seventh position in 2000. Cancer cases have doubled in the last 20 years. According to WHO,
With 700,000 deaths, 1.1 million new cases every year, 3.3 million patients at any given time,
cancer has emerged as a leading killer for the first time. GI cancer is not one cancer but is a
term for the group of cancers that affect the digestive system. Overall, the GI cancers are
responsible for more cancers and more deaths from cancer than any other organ. 5 year
survival of these cancers remains low compared to western world. These figures are
distressing. However, at the same time it is also true that early detection and timely surgical
intervention in the early stages of cancer can prevent many such deaths.
The prime problem in the diagnosis of the GI cancers is that their early symptoms — like loss
of appetite, indigestion, nausea, heartburn, coughing, difficulty in swallowing, weight loss,
frequent choking while eating, stomach pain and change in bowel habits, bleeding per rectum
— are often overlooked by the patient until serious symptoms show up, but, by that time the
cancer has already progressed to advanced stages. Considering this aspect, it is highly
imperative that people should not neglect the early symptoms
Once the cancer has been detected, its stage is determined by CT Scan and or MRI. Taking
into account the cancer stage, the therapy is initiated. Usually, in the initial stages, surgery is
needed to remove the cancerous cells from the affected site. In the middle stages, a
combination of surgery and chemotherapy is put into application, while in advanced stages
generally chemotherapy is the only option.
Often the surgeries require resection of the oesophagus, stomach, colon, rectum or abdominal
perineal resection in case of oesophageal, stomach and colorectal cancer respectively. In the
conventional procedure, this is done invasively by making a large abdominal cut which
results in a large scar, higher risk of complications and hospital acquired infection, more pain
after surgery, long hospital stay and a long recovery period.
However, now with the advent of minimally invasive technique, surgery has become
extremely patient-friendly. Unlike the conventional procedure, in the laparoscopic method
few very small incisions are made to carry out the operation. This approach has the same
success rate as standard open surgery along with potential benefits for the patient like it
causes smaller scar, less blood loss, less risk of hospital acquired infection, less pain after the
surgery, shorter hospital stay and faster recovery.
Laparoscopic surgery reflects the evolution of an exciting collaboration between surgeons
and the science of biotechnology. Additionally, robotic surgery and single port surgery will
become additional options in minimally invasive surgery as much validation needs to be used
in clinical fields. Laparoscopic GI cancer operations are more difficult to perform than are
other laparoscopic procedures.
Another important thing is education. As the number of laparoscopic GI surgeries has
increased rapidly, the importance of education for laparoscopic skills became higher. More
refined focussed domestic training workshops and international collaborations will promise to
progress advanced laparoscopic GI surgery. All these efforts and technical advancements will
finally improve the quality of life of patients suffering from GI diseases
It is clear that laparoscopic surgery has gained acceptance and with time has earned its
rightful niche in the field of gastrointestinal surgery. As patient satisfaction grows and as
clinical outcomes improves significantly with better trained surgeons, the light and dynamism
of laparoscopic surgery will continue to illuminate the resolution of gastrointestinal disease
processes including cancer.
- September 23, 2019
Homoeopathy is expected to be the Medicine of 21 st Century era. Homoeopathy today is a rapidly growing system and is being practiced almost all over the world. In India it has become a household name due the safety of its pills and effectiveness of its cure. It is considered as the Second most popular system of medicine in the Country even WHO endorses it’s prevalence in many countries of the world including Europe, Asia, African Countries and Gulf etc. It is more than a century and a half now that Homoeopathy is being practiced in India. It has blended so well into the roots and traditions of the country that it has been recognised as one of the National System of Medicine and plays a very important role in providing health care to a large number of people. Its strength lies in its evident effectiveness as it takes a holistic approach towards the sick individual through promotion of inner balance (or homoeostasis) at mental, emotional, spiritual and physical levels. It is based on the natural law of healing- "Similia Similibus Curantur” which means "likes are cured by likes”. It was given a scientific basis by Dr. Samuel Hahnemann in the early 19th century. It has been serving suffering humanity for over two centuries and has withstood the upheavals of time and has emerged as a time-tested therapy, for the scientific principles propounded by Hahnemann are natural and well proven and continue to be followed with success even today. Homoeopathy is a system of medicine which deals with the individualisation of the patient and treats the sick on the basis by considering the Mental, Physical, Emotional, Environmental and Circumstantial symptoms of the patient and not merely the symptoms of the disease. That’s why many patients suffering from the same diseases are being treated and cured with different medicines and not everyone is given the same medicines. Constitutional Treatment in Homoeopathy is the one which takes care of that patient thoroughly. India is only country in the world which has separate ministry of Homeopathy and it comes under the Ministry of AYUSH. The country is the biggest hub and is the go-to place when it comes for homeopathy. Having such a ministry for Homeopathy strengthens homeopathy’s claim to be part of the mainstream healthcare. Not only this, under AYUSH, there is a full-fledged research unit for Homeopathy, which is known as Central Council of Research for Homeopathy (CCRH) AYUSH has got multiple research units PAN India, CCH (Central Council of Homoeopathy) looks after the Education.
Government has allocated a substantial budget specifically for AYUSH, for research, treatment of patients and organising CME, educational programs and publications. The ministry of AYUSH is conducting multiple Health Projects. It has provided homeopathic consultation and treatment to over 1 lakh patients in the villages of India, thus creating a world record. If the entire budget of AYUSH is distributed and intelligently utilised, it will
create a wonderful quality of health across the entire population of India. The Indian government is financing multiple peripheral units for research on specific clinical conditions through colleges and research conducted by
individual doctors. All this research work is being published and circulated around the globe on a regular basis.
Moreover, government is also planning to support a highly evolved Medical Institutions to deliver quality Healthcare research all under one roof; which will be known as AIIMS (All India Institute of Medical Science – Homeopathy). These are some of the developments when it comes to Homeopathy in India, thus clearly indicating the importance of this therapy.
There are several reasons why Homeopathy is considered better than other systems of medicine. Apart from being pocket-friendly, this treatment focuses on improving immunity and reducing the disease recurrence. While most of the systems of medicines have one or more proven side effects, there are no such adverse effects from Homeopathy, as they are chemical free and potentized. Moreover, the Homeopathy medicines have a longer shelf life, which is a boon for the developing economy like ours. Homoeopathy Ensures Health Safely and Effectively is the one main reason for people to opt it as first line of treatment in the era of AYUSH .
President – HMAI, Delhi
RU-115, Pitam Pura, New Delhi